tony schwartz on the campaign. see you. >>> we're going to fit in a break. chris hayes is here -- you're thinking is it the right hour? it is. chris hayes, live and direct, next. s hayes, live and direct, next ♪♪ over 400,000 people have left blood thinners behind with watchman. watchman is a safe, minimally—invasive, one—time implant that reduces stroke risk and bleeding worry, for life. ♪♪ watchman. it's one time, for a lifetime. oooh! this is our night! shingles doesn't care. but shingrix protects. only shingrix is proven over 90% effective. shingrix is a vaccine used to prevent shingles in adults 50 years and older. shingrix does not protect everyone and is not for those with severe allergic reactions to its ingredients or to a previous dose. an increased risk of guillain-barré syndrome was observed after getting shingrix. fainting can also happen. the most common side effects are pain, redness, and swelling at the injection site, muscle pain, tiredness, headache, shivering, fever, and upset stomach. ask your d

tony schwartz , next.t is taken once every 8 weeks. ( ♪♪ ) fasenra helps prevent asthma attacks. most patients did not have an attack in the first year. fasenra is proven to help you breathe better so you can get back to doing day-to-day activities. and fasenra helps lower the use of oral steroids. fasenra is not for sudden breathing problems or other eosinophilic conditions. allergic reactions may occur. don't stop your asthma treatments without talking with your doctor. tell your doctor if your asthma worsens. headache and sore throat may occur. tell your doctor if you have a parasitic infection. get back to better breathing. get back to what you've missed. ask your doctor about fasenra, the only asthma treatment taken once every 8 weeks. if you can't afford your medication, astrazeneca may be able to help. my fear of recurrence could've held me back. but i'm staying focused. and doing more to prevent recurrence. verzenio is specifically for hr-positive, her2-negative, node-positive early breast cancer w